• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织型纤溶酶原激活剂与尿激酶原的疗效及特异性比较研究:协同作用及不同非选择性阈值的证明

A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity.

作者信息

Gurewich V, Pannell R

出版信息

Thromb Res. 1986 Oct 15;44(2):217-28. doi: 10.1016/0049-3848(86)90137-4.

DOI:10.1016/0049-3848(86)90137-4
PMID:3097872
Abstract

Clot lysis and non-specific plasminogen activation in human plasma by tissue tissue plasminogen activator (t-PA) and/or pro-urokinase (pro-UK) were studied. The fibrinolytic activity of pro-UK was expressed as latent units, i.e. measured after activation with plasmin on a fibrin plate against the reference standard. The t-PA unitage was assigned on a weight basis of a similar equivalence of 100,000 IU/mg. To simplify comparison, both activators were expressed in IU (1 IU = approximately 10 ng). At low concentration (1-50 IU/ml), t-PA induced more effective and more linear clot lysis, whereas pro-UK induced lysis was preceded by a lag phase. The two activators were equivalently effective at higher concentrations and saturated at the same lysis rate. Clots made from platelet rich plasma or whole blood were more responsive to lysis by pro-UK but not t-PA than corresponding platelet poor clots. At very low concentrations (2.5-5 IU/ml) of t-PA combined with moderate concentrations (25-50 IU/ml) of pro-UK, a synergistic effect on clot lysis, which was fibrin-specific, was observed. Plasminogen and fibrinogen and the appearance of plasmin-inhibitor complexes in plasma were measured after incubation with either activator with and without a clot present. Non-specific plasminogen activation occurred above a certain concentration of either activator but was found at lower concentrations of t-PA than pro-UK. In the absence of a clot, plasmin generation occurred with t-PA at about 30% of the concentration at which pro-UK induced a corresponding effect. It is concluded that there are important differences in the fibrinolytic and clot selective properties of t-PA and pro-UK, and that some of these properties may be complementary resulting in a fibrin specific, synergistic fibrinolytic effect.

摘要

研究了组织型纤溶酶原激活剂(t-PA)和/或尿激酶原(pro-UK)对人血浆中凝块溶解及非特异性纤溶酶原激活的作用。尿激酶原的纤溶活性以潜在单位表示,即在纤维蛋白平板上用纤溶酶激活后,相对于参考标准进行测量。t-PA的单位活性是根据100,000 IU/mg的相似等效重量确定的。为简化比较,两种激活剂均以IU表示(1 IU约等于10 ng)。在低浓度(1 - 50 IU/ml)时,t-PA诱导的凝块溶解更有效且更呈线性,而尿激酶原诱导的溶解之前有一个延迟期。两种激活剂在较高浓度时等效有效,且以相同的溶解速率达到饱和。由富含血小板血浆或全血制成的凝块比相应的贫血小板凝块对尿激酶原诱导的溶解更敏感,但对t-PA不敏感。在极低浓度(2.5 - 5 IU/ml)的t-PA与中等浓度(25 - 50 IU/ml)的尿激酶原联合使用时,观察到对凝块溶解有纤维蛋白特异性的协同作用。在有或无凝块存在的情况下,将血浆与任一种激活剂孵育后,测量血浆中的纤溶酶原、纤维蛋白原以及纤溶酶 - 抑制剂复合物的出现情况。在任一种激活剂的特定浓度以上会发生非特异性纤溶酶原激活,但发现t-PA的浓度低于尿激酶原。在无凝块的情况下,t-PA诱导纤溶酶生成的浓度约为尿激酶原诱导相应作用浓度的30%。结论是,t-PA和尿激酶原在纤溶和凝块选择性特性方面存在重要差异,并且其中一些特性可能具有互补性,从而产生纤维蛋白特异性的协同纤溶作用。

相似文献

1
A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity.组织型纤溶酶原激活剂与尿激酶原的疗效及特异性比较研究:协同作用及不同非选择性阈值的证明
Thromb Res. 1986 Oct 15;44(2):217-28. doi: 10.1016/0049-3848(86)90137-4.
2
Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.组织型纤溶酶原激活剂和尿激酶原的互补作用模式,据此可解释它们对血栓溶解的协同效应。
J Clin Invest. 1988 Mar;81(3):853-9. doi: 10.1172/JCI113394.
3
A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.纤维蛋白D片段和E-2片段对组织型纤溶酶原激活物及尿激酶原诱导的纤溶酶原激活作用的促进作用的比较研究
J Clin Invest. 1991 Dec;88(6):2012-7. doi: 10.1172/JCI115528.
4
Effect of fibrin-targeting on clot lysis with urokinase-type plasminogen activator.纤维蛋白靶向对尿激酶型纤溶酶原激活剂溶栓作用的影响。
Thromb Res. 1990 Feb 1;57(3):333-42. doi: 10.1016/0049-3848(90)90249-c.
5
Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect.尿激酶原:其在血浆中的稳定性及选择性纤溶作用机制的研究
Blood. 1986 May;67(5):1215-23.
6
Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis.
Thromb Haemost. 1994 Mar;71(3):347-52.
7
Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.组织型纤溶酶原激活剂(t-PA)、单链尿激酶型纤溶酶原激活剂(scu-PA)和尿激酶在体外血浆环境中对血凝块溶解不存在协同作用。
Thromb Haemost. 1986 Aug 20;56(1):35-9.
8
Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158).通过对赖氨酸(158)位点特异性诱变产生的抗纤溶酶突变体形式的研究,对尿激酶原的内在纤溶特性进行表征。
J Clin Invest. 1988 Dec;82(6):1956-62. doi: 10.1172/JCI113815.
9
Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.回缩对使用纤维蛋白特异性和非纤维蛋白特异性纤溶酶原激活剂溶解人血凝块的影响。
Thromb Haemost. 1989 Dec 29;62(4):1083-7.
10
Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.组织型纤溶酶原激活剂与尿激酶在体外的相对纤维蛋白溶解、纤溶及溶栓特性比较
Thromb Haemost. 1981 Jun 30;45(3):225-9.

引用本文的文献

1
Is thrombolysis alone the best therapy for acute myocardial infarction? Current status and emerging strategies.单纯溶栓是急性心肌梗死的最佳治疗方法吗?现状与新策略
Tex Heart Inst J. 1991;18(1):50-61.
2
Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158).通过对赖氨酸(158)位点特异性诱变产生的抗纤溶酶突变体形式的研究,对尿激酶原的内在纤溶特性进行表征。
J Clin Invest. 1988 Dec;82(6):1956-62. doi: 10.1172/JCI113815.
3
Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
组织型纤溶酶原激活剂和尿激酶原的互补作用模式,据此可解释它们对血栓溶解的协同效应。
J Clin Invest. 1988 Mar;81(3):853-9. doi: 10.1172/JCI113394.
4
Binding of plasminogen activators to fibrin: characterization and pharmacological consequences.纤溶酶原激活剂与纤维蛋白的结合:特性及药理学后果
Biochem J. 1989 Jul 15;261(2):313-24. doi: 10.1042/bj2610313.